Upsher Smith Laboratories recalls

Upsher Smith Laboratories has 6 recalls on record with the FDA and USDA, the earliest in 2013 and the latest reported on 28 Aug 2019. The most frequent reason is potency & assay.

Total recalls6since 2013

Last 12 months0reported

Class I00% of total

Ongoing0latest 28 Aug 2019

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 4 67%Class III 2 33%

Why upsher smith laboratories is recalled

Product types

Blood Pressure Medication117%
Seizure Medication117%

Brands

Bumetanide233%
Bexarotene117%

By year

2019117%
2018233%
2014117%
2013233%

All upsher smith laboratories recalls, newest first

6 total

Reported	Class	Recall	Company	Reason	Where
28 Aug 2019Drug	CLASS II	Bexarotene Capsules, 75 mg recalled by Upsher Smith LaboratoriesBexarotene	Upsher Smith Laboratories	Potency & Assay	4 states
31 Oct 2018Drug	CLASS II	Bumetanide Tablets, USP, 1 mg recalled by Upsher Smith LaboratoriesBumetanide	Upsher Smith Laboratories	Potency & Assay	Nationwide
31 Oct 2018Drug	CLASS II	Bumetanide Tablets, USP, 2 mg recalled by Upsher Smith LaboratoriesBumetanide	Upsher Smith Laboratories	Potency & Assay	Nationwide
30 Apr 2014Drug	CLASS III	Oxandrolone Tablets, USP, 10 mg recalled by Upsher Smith Laboratories	Upsher Smith Laboratories	Labeling Errors	Nationwide
20 Feb 2013Drug	CLASS II	Propranolol Hydrochloride Extended-release Capsules, USP, 80 mg recalled	Upsher Smith Laboratories	Potency & Assay	FL, NJ
23 Jan 2013Drug	CLASS III	Divalproex Sodium Delayed-Release Tablets recalled	Upsher Smith Laboratories	Other	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.